ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Inctye’s Pemazyre authorised in the EU for bile duct cancer
March 30, 2021The European Commission (EC) has approved Incyte’s kinase inhibitor Pemazyre for the treatment of certain patients with advanced cholangiocarcinoma, also known as bile duct cancer. -
RenovoRx Announces Orphan Drug Designation Granted for Treating Bile Duct Cancer
June 15, 2020RenovoRx announced the U.S. Food and Drug Administration (FDA) has granted the Company orphan drug designation for treating bile duct cancer, also known as cholangiocarcinoma, with intra-arterial gemcitabine.
Pharma Sources Insight January 2025
